Invention Grant
- Patent Title: Beta-galactosidase variant having high transglycosylation activity, and use thereof
-
Application No.: US15574559Application Date: 2016-05-19
-
Publication No.: US10526592B2Publication Date: 2020-01-07
- Inventor: Su Jin Kim , Young-Jae Eu , Taek Ho Yang , Jae Gu Pan , Eui Joong Kim
- Applicant: GENOFOCUS CO., LTD.
- Applicant Address: KR Daejeon
- Assignee: GENOFOCUS CO., LTD.
- Current Assignee: GENOFOCUS CO., LTD.
- Current Assignee Address: KR Daejeon
- Agency: Hultquist, PLLC
- Agent Steven J. Hultquist
- Priority: KR10-2015-0074862 20150528
- International Application: PCT/KR2016/005335 WO 20160519
- International Announcement: WO2016/190613 WO 20161201
- Main IPC: C12N9/24
- IPC: C12N9/24 ; C12P19/04 ; C12N15/75 ; C12N15/80 ; C12N15/81 ; C12P19/14

Abstract:
The present invention relates to a beta-galactosidase mutant having high transglycosylation activity and containing a C-terminal deletion, and the use thereof and more. More specifically, the present invention relates to a beta-galactosidase mutant having a C-terminal deletion, a gene encoding the same, a recombinant vector containing the gene, a recombinant microorganism transformed with the gene or the recombinant vector, and a method for producing the beta-galactosidase mutant using the recombinant microorganism. Using the high transglycosylation activity of the beta-galactosidase mutant containing the C-terminal deletion according to the present invention, galactooligosaccharide can be efficiently produced in large amounts.
Public/Granted literature
- US20180155699A1 BETA-GALACTOSIDASE VARIANT HAVING HIGH TRANSGLYCOSYLATION ACTIVITY, AND USE THEREOF Public/Granted day:2018-06-07
Information query